Cyclo Therapeutics (NASDAQ:CYTH – Get Rating) is one of 41 publicly-traded companies in the “Industrial organic chemicals” industry, but how does it weigh in compared to its rivals? We will compare Cyclo Therapeutics to similar companies based on the strength of its institutional ownership, dividends, profitability, analyst recommendations, risk, earnings and valuation. Insider & Institutional […]